Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.32 |
| ▸ | RHOC | P08134 | 1/20 | 0.31 |
| ▸ | RHOA | P61586 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25427876 | 0.89 | — | — | |
| SCHEMBL9675023 | 0.81 | FFAR2 (0.40) | DAOKDM4ENPC1TDP1FFAR2 | |
| Carbamic Acid SCHEMBL9677239 | 0.80 | FFAR2 (0.39) | DAOKDM4ENPC1TDP1FFAR2 | |
| SCHEMBL24917625 | 0.79 | HDAC3 (0.35) | KDM4ENPC1RAB9ASMN1; SMN2HTT | |
| SCHEMBL24917626 | 0.78 | IDH1 (0.31) | KDM4ENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL20640303 | 0.78 | GABRA5 (0.44) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL31555059 | 0.77 | CYP1A2 (0.37) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL30527974 | 0.77 | ECE1 (0.40) | KDM4EMEN1KMT2ANPSR1 | |
| SCHEMBL25427966 | 0.76 | TSHR (0.42) | DAOKDM4ENPC1RAB9AMEN1 | |
| SCHEMBL3159540 | 0.76 | IDH1 (0.39) | KDM4EFFAR2MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118647270-A | Novel derivatives of non-coding amino acids and their use as herbicides | 福提费斯特有限公司 | 2024-09-13 | — | — | CN | claimed |
| WO-2023131951-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD. (IL) | 2023-07-13 | — | — | WO | claimed |
| CN-118647270-A | Novel derivatives of non-coding amino acids and their use as herbicides | 福提费斯特有限公司 | 2024-09-13 | — | — | CN | disclosed |
| US-20240284907-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD. (IL) | 2024-08-29 | — | — | US | disclosed |
| EP-4369933-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | Fortephest Ltd. (IL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023131951-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD. (IL) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023286057-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD (IL) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023286057-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD (IL) | 2023-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240284907-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | DDT, DDC, GLUL | DAO 7/4885KDM4E 388/4885NPC1 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.